Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tvardi Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Tvardi Therapeutics

Tvardi Therapeutics

Tvardi Therapeutics: Pioneering breakthrough medicines for cancers and chronic diseases since 2017.

HQ
Houston, TX, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Tvardi Therapeutics is a clinical-stage biotechnology company founded in 2017 and based in Houston, Texas. The company is dedicated to developing breakthrough medicines targeting diverse cancers, chronic inflammatory diseases, and fibrotic diseases. Tvardi's innovative approach focuses on creating a new class of therapies, including their novel STAT3 inhibitor, TTI-101, which is currently undergoing clinical trials.

Tvardi Therapeutics has made significant strides in the biotech industry, including presenting their Phase 1 clinical trial results for liver cancer at the ASCO Gastrointestinal Cancers Symposium. The company has attracted notable leadership, with Sujal Shah appointed as Chairman and Shaheen Wirk joining the Board of Directors. Tvardi continues to participate in prominent industry conferences, such as the Cowen 44th Annual Health Care Conference, showcasing their commitment to advancing medical research and treatment options.

Tvardi Therapeutics - Similar Companies

Tavros Therapeutics logo

Tavros Therapeutics

Starton Therapeutics logo

Starton Therapeutics

Treadwell Therapeutics logo

Treadwell Therapeutics

treadwelltx.com

Therini Bio logo

Therini Bio

therinibio.com

Tavotek Biotherapeutics logo

Tavotek Biotherapeutics

tavotek.com

Tigris Pharmaceuticals logo

Tigris Pharmaceuticals

tigrispharma.com

Stellanova Therapeutics logo

Stellanova Therapeutics

stellanovatx.com

Star Therapeutics logo

Star Therapeutics

Flare Therapeutics logo

Flare Therapeutics

flaretx.com

Tachyon Therapeutics logo

Tachyon Therapeutics

tachyontx.com

TG Therapeutics logo

TG Therapeutics

tgtherapeutics.com

Tactiva Therapeutics logo

Tactiva Therapeutics

Iterion Therapeutics logo

Iterion Therapeutics

Blade Therapeutics logo

Blade Therapeutics

Torl Biotherapeutics logo

Torl Biotherapeutics

torlbio.com

Tvardi Therapeutics - Quick Facts

Who are Tvardi Therapeutics' competitors?

Companies similar to Tvardi Therapeutics include Tavros Therapeutics, Starton Therapeutics, Treadwell Therapeutics and Therini Bio.

When was Tvardi Therapeutics founded?

Tvardi Therapeutics was founded in 2017.

Where is Tvardi Therapeutics' headquarters located?

Tvardi Therapeutics' headquarters is located in Houston, TX, US.

When was Tvardi Therapeutics' last funding round?

Tvardi Therapeutics' most recent funding round was for $72.4M (USD) in June 2021.

How much has Tvardi Therapeutics raised to-date?

As of Jun 15, 2021, Tvardi Therapeutics has raised a total of $81.4M (USD).

How many employees does Tvardi Therapeutics have?

Tvardi Therapeutics has 20 employees as of Feb 5, 2024.

Tvardi Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biotechnology
  • Therapeutics
Tags
  • SaaS
Unique IDs
  • ein: 000000000
  • secCik: 0001346830
  • ticker: TVRD
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified